1. CAS Reg. No. 142797-34-0. 2. CAS Reg. No. 65666-07-1. 3. CAS Reg. No. 36804-18-9. BAY 2666605 1 is a phosphodiesterase 3 (PDE3) inhibitor that is being developed to combat melanoma. It is active ...

The FDA approved inhaled ensifentrine (Ohtuvayre) as maintenance treatment for chronic obstructive pulmonary disease (COPD) in adults, drugmaker Verona Pharma announced on Wednesday. A first-in ...

Supporting Indian cities' infrastructure development is crucial for economic growth, public amenities, and sustainable urban planning, emphasized by experts.